This is in contrast to prior works [Bennett et al., 2025, Chai-Discovery et al., 2025, Mille-Fragoso et al., 2025], where the target commonly appears in the training data in a bound context (Supplementary Section C.1)
Smart PLS analysis [58] was utilized to investigate the causal links between the lowest SpO2 and PBT in the acute phase and the neuropsychiatric symptoms in Long COVID, whereby the effects of SpO2 and temperature are mediated by IO&NS biomarkers
In addition, numerous studies have demonstrated that several common clinical drugs can target SLC1A5 and inhibit tumor progression
however, the exact mechanisms by which UA interacts with misfolded proteins remain unclear
Abstract: Zeevalk, G
Sign three: breakouts worsen over time Purging starts bad and gets progressively better